Why Are Triptans and Ergot Drugs Avoided in CADASIL?

If you have CADASIL, your neurologist may have advised you against using common migraine rescue medications like triptans (such as sumatriptan) and ergot derivatives (such as dihydroergotamine). Always remember not to start or stop any medication without discussing it with your prescribing doctor. The caution around these drugs is due to how they work. Triptans and ergots help stop migraines in part by narrowing blood vessels, a process called vasoconstriction ^[1][2]. Because CADASIL causes damage to the small blood vessels in the brain, experts often recommend a precautionary approach to avoid further narrowing these vessels, which could theoretically increase the risk of a transient ischemic attack (TIA) or stroke ^[3][4].

The Biology: Vessel Walls and Vasoconstriction

CADASIL is caused by mutations in the NOTCH3 gene. This mutation damages vascular smooth muscle cells, which are located within the walls of small arteries and help regulate blood flow ^[5]. Over time, these vessel walls thicken, stiffen, and lose their ability to efficiently expand and contract ^[3]. This reduces the brain’s baseline blood flow and its ability to easily adapt to changes in pressure ^[6].

Triptans relieve migraines by acting on specific nerve pathways and receptors (5-HT1B/1D) that cause blood vessels to constrict ^[1][7]. Ergot derivatives have a similar vasoconstrictive effect ^[8]. While direct evidence proving that a single dose of these drugs inevitably causes a stroke specifically in CADASIL is limited ^[9], formal medication labels often contraindicate their use in people with a history of stroke or TIA ^[10][11]. Because of the underlying vessel damage and reduced blood flow reserve in CADASIL, many specialists apply this precaution to all CADASIL patients to avoid risking a critical reduction in blood supply ^[12].

Non-Constricting Alternative Treatments

Avoiding triptans and ergots does not mean you have to endure migraines without treatment. There are alternative rescue treatments that do not constrict blood vessels, though each has its own safety profile that you should review with your doctor:

• Traditional Pain Relievers: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen do not constrict blood vessels ^[13]. However, NSAIDs can increase blood pressure or carry risks of gastrointestinal bleeding and kidney issues, especially if you take blood thinners or other interacting medications.
• Antiemetics: Dopamine-blocking anti-nausea medications can interrupt a migraine without constricting vessels ^[14]. They are not risk-free, as they can cause sedation, involuntary movements, or heart-rhythm changes.
• Gepants: Newer medications (like ubrogepant or rimegepant) block CGRP, a protein involved in migraine pain, without causing vasoconstriction ^[14]. While long-term CADASIL-specific safety data is still developing, they do not carry the vascular warnings of triptans, though they require review for drug interactions and liver health ^[15].
• Ditans: Lasmiditan targets different receptors (5-HT1F) to stop pain without constricting blood vessels ^[16]. However, it commonly causes significant dizziness and sedation, and patients are strictly restricted from driving or operating machinery for at least 8 hours after taking a dose ^[17].

Recognizing Emergencies: When It Is Not Just a Migraine

Some neurological symptoms of CADASIL can mimic a migraine aura, but because CADASIL increases your risk of stroke, it can be dangerous to assume every neurological symptom is just an aura ^[18]. Do not wait for symptoms to pass or just take rescue medication. Seek immediate emergency medical care (call your local emergency number) if you experience:

• Sudden weakness or numbness, especially on one side of the face or body
• Facial drooping
• Sudden difficulty speaking or understanding speech
• Sudden vision loss or severe balance issues
• A sudden, unusually severe “thunderclap” headache

Working With Your Care Team

Finding the right migraine plan requires an individualized approach. Because CADASIL is rare, medical recommendations are often based on expert consensus rather than large clinical trials ^[12]. Track your attacks in a headache diary—noting frequency, aura symptoms, what medications you take, and if any symptoms are new or unusual. Discuss preventive migraine treatments with your neurologist, which can help reduce how often you need acute rescue medications in the first place.